Abstract:Background: Human and mouse natural killer (NK) cells have been shown to develop memory-like function after short-term exposure to the cocktail of IL-12/15/18 or to overnight co-culture with some tumor cell lines. The resulting cells retain enhanced lytic ability for up to 7 days as well as after cryopreservation, and memory-like NK cells (mlNK) have been shown to induce complete remissions in patients with hematological malignancies. No single phenotype has been described for mlNK and the physiological changes induced by the short-term cytokine or tumor-priming which are responsible for these enhanced functions have not been fully characterized. Here, we have generated mlNK by cytokine and tumor-priming to find commonalities to better define the nature of NK cell "memory" in vitro and, for the first time, in vivo. Methods: We initiated mlNK in vitro from healthy donors with cytokines (initiated cytokine-induced memory-like (iCIML)-NK) and by tumor priming (TpNK) overnight and compared them by high-dimensional flow cytometry, proteomic and metabolomic profiling. As a potential mechanism of enhanced cytolytic function, we analyzed the avidity of binding of the mlNK to NK-resistant tumors (z-Movi). We generated TpNK from healthy donors and from cancer patients to determine whether mlNK generated by interaction with a single tumor type could enhance lytic activity. Finally, we used a replication-incompetent tumor cell line (INKmune) to treat patients with myeloid leukaemias to potentiate NK cell function in vivo. Results: Tumor-primed mlNK from healthy donors and patients with cancer showed increased cytotoxicity against multiple tumor cell lines in vitro, analogous to iCIML-NK cells. Multidimensional cytometry identified distinct memory-like profiles of subsets of cells with memory-like characteristics; upregulation of CD57, CD69, CD25 and ICAM1. Proteomic profiling identified 41 proteins restricted to mlNK cells and we identified candidate molecules for the basis of NK memory which can explain how mlNK overcome inhibition by resistant tumors. Finally, of five patients with myelodysplastic syndrome or refractory acute myeloid leukemia treated with INKmune, three responded to treatment with measurable increases in NK lytic function and systemic cytokines. Conclusions: NK cell "memory" is a physiological state associated with resistance to MHC-mediated inhibition, increased metabolic function, mitochondrial fitness and avidity to NK-resistant target cells.

Natural killer cell memory in infection, inflammation and cancer

Natural Killer Cell Memory: Progress and Implications

Memory-Like NK Cells: Remembering a Previous Activation by Cytokines and NK Cell Receptors

The Ire1 Endoplasmic Reticulum Stress Sensor Activates Natural Killer Cell Immunity And Promotes Natural Killer Cell Memory By Regulating C-Myc And Mitochondrial Respiration

Advance in memory NK cells study

Emerging Insights into Memory Natural Killer Cells and Clinical Applications

Proteomic and phenotypic characteristics of memory-like natural killer cells for cancer immunotherapy

Memory NK Cell Features Exploitable in Anticancer Immunotherapy

Epigenetic control of innate and adaptive immune memory

Enhanced expression of natural cytotoxicity receptors on cytokine-induced memory-like natural killer cells correlates with effector function

Innate or Adaptive Immunity? The Example of Natural Killer Cells

Tissue‐resident memory NK cells: Homing in on local effectors and regulators

Innate Lymphoid Cell Memory

Extrinsic and intrinsic drivers of natural killer cell clonality

Innate Immune Memory and the Host Response to Infection

Immunological memory: lessons from the past and a look to the future

Adaptive natural killer cell expression in response to cytomegalovirus infection in blood and solid cancer

The Anti-Tumor Role of NK Cells in Vivo Pre-Activated and Re-Stimulated by Interleukins in Acute Lymphoblastic Leukemia.

Roles of natural killer cells in immunity to cancer, and applications to immunotherapy

Human natural killer cells mediate adaptive immunity to viral antigens

Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization